Back
AAC Technologies Holdings, Inc. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison
Sell
42
AACAY
AAC Technologies Holdings, Inc.
Last Price:
$4.87
Seasonality Move:
3.52%
Sell
23
RARE
Ultragenyx Pharmaceutical, Inc.
Last Price:
$32.80
Seasonality Move:
-0.96%
Sell
42
AAC Technologies Holdings, Inc. (AACAY)
is a Sell
Is AAC Technologies Holdings, Inc. a Buy, Sell or Hold?
-
The current AAC Technologies Holdings, Inc. [AACAY] share price is $4.79. The Score for AACAY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
AACAY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.21. The Score for RARE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AACAY Stock Price Chart
What is AAC Technologies Holdings, Inc.'s stock price today?
-
The AAC Technologies Holdings, Inc. share price today is $4.79Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AACAY is experiencing selling pressure, which indicates risk of future bearish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical, Inc.'s stock price today?
-
The Ultragenyx Pharmaceutical, Inc. share price today is $33.21Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
AACAY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 44.24 | Sell |
| Chaikin Money Flow: | -10078 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.73 - 5.01) | Sell |
| Bollinger Bands (100): | (4.9 - 5.74) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.65 | Buy |
| Relative Strength Index (14 RSI): | 43.13 | Sell |
| Chaikin Money Flow: | -1062961 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.65 - 35.95) | Sell |
| Bollinger Bands (100): | (29.01 - 34.13) | Buy |
AACAY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.87 | Sell |
| 20-day SMA: | 4.83 | Sell |
| 50-day SMA: | 5.01 | Sell |
| 200-day SMA: | 5.24 | Sell |
| 8-day EMA: | 4.85 | Sell |
| 20-day EMA: | 4.88 | Sell |
| 50-day EMA: | 5.03 | Sell |
| 200-day EMA: | 5.08 | Sell |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.62 | Sell |
| 20-day SMA: | 34.63 | Sell |
| 50-day SMA: | 33.66 | Sell |
| 200-day SMA: | 33.65 | Sell |
| 8-day EMA: | 7.38 | Buy |
| 20-day EMA: | 3.16 | Buy |
| 50-day EMA: | 1.3 | Buy |
| 200-day EMA: | 0.33 | Buy |
AAC Technologies Holdings, Inc. Earnings Growth & AACAY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.
AAC Technologies Holdings, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||